NSCLC: Integrating EGFR-Inhibiting Therapies into Clinical Pathways for First-Line Treatment

This video is part of the HMP Education content archive and may include previously accredited educational material. While this video is no longer eligible for CE credit, the clinical insights and educational discussions remain available for ongoing learning purposes. Learners should note that the content may not reflect the most current standards of care and should not be used as a substitute for independent clinical judgment, current accredited education, or updated clinical guidelines. For the latest accredited CE activities and certified educational programming, please visit HMP Education at https://hmpeducation.com/